Mark manfredi ikenaoncology.com
WebShared by Mark Manfredi. Proud of the Ikena Oncology team for their innovative work on this program. The promise of MEK as a target has … WebAt Ikena, we strive to understand what drives every patient’s cancer. Each member of our team is committed to this goal and offers their unique set of experiences and talents to …
Mark manfredi ikenaoncology.com
Did you know?
WebAlso Known As Kyn Therapeutics. Legal Name Ikena Oncology, Inc. Stock Symbol NASDAQ:IKNA. Company Type For Profit. Contact Email [email protected]. Phone Number +1 857 273 8343. Ikena Oncology is a targeted oncology company focused on developing cancer therapies targeting key signaling pathways that drive the formation …
Web6 sep. 2024 · BOSTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced ... WebMark Manfredi, Ph.D., President and Chief Executive Officer of Ikena Oncology, commented, “Ikena Oncology represents the growth and evolution of our vision, strategy, …
WebMark Manfredi @markgmanfredi a week ago Very proud of the Ikena team for the progress across our pipeline from delivery of clinical data on IK-175 in bladder cancer, dose … WebAt Ikena, we strive to understand what drives every patient’s cancer. Each member of our team is committed to this goal and offers their unique set of experiences and talents to help us achieve it. Leadership Mark Manfredi, Ph.D. PRESIDENT AND CHIEF EXECUTIVE OFFICER Jeffrey Ecsedy, Ph.D. CHIEF DEVELOPMENT OFFICER Jotin Marango, …
Web6 apr. 2024 · Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling …
Web28 feb. 2024 · Presenter: Mark Manfredi, Ph.D., Chief Executive Officer of Ikena Oncology Date: Tuesday, March 7, 2024 Time: 2:10pm-3:10pm EST Webcast Link: Targeted Oncology Panel The webcast link will stream the live panel and will be archived for 30 days following the end of the conference, accessible above. ma borne auto sainghinWeb20 uur geleden · Ikena Oncology 8,517 followers 1y Our president and CEO Mark Manfredi, Ph.D., discussed Ikena’s unique corporate culture and goal to create a vibrant, … ma bonne viande avisWeb10 apr. 2024 · Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet needs in the United States. About the company Rewards Revenue is forecast to grow 19.97% per year Risk Analysis Earnings are forecast to decline by an average of 16.8% per year for the next 3 … mabore pradopolisWebIkena Oncology contact info: Phone number: (857) 273-8343 Website: www.ikenaoncology.com What does Ikena Oncology do? Ikena Oncology is a clinical … costco laser printer in storeWeb8 jul. 2024 · BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies targeting key signaling pathways that drive the formation ... mabon simmer potWeb28 feb. 2024 · Presenter: Mark Manfredi, Ph.D., Chief Executive Officer of Ikena Oncology Date: Tuesday, March 7, 2024 Time: 2:10pm-3:10pm EST Webcast Link: Targeted … costco last minute travelWeb/s/ Mark Manfredi: 01/05/2024 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the … ma bo restaurant liverpool